Julia S Arzeno, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 37
- 9 carriers
- Office
- 1
Offices
1 location · Csi Medical Group · 104 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
37 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Arzeno’s office at (408) 369-5600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
37 of 37 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A160666 · Current
Licensed to practise in California · since 2019 · expires 2027-02-28 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$644,639
Medicare paid this office $644,639 for 597 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 357 | $197,570 | $478 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 193 | $114,479 | $372 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 101 | $60,602 | $532 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 51 | $45,212 | $869 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 138 | $30,127 | $211 |
See all 30 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 357 | $197,570 | $478 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 193 | $114,479 | $372 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 101 | $60,602 | $532 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 51 | $45,212 | $869 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 138 | $30,127 | $211 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 109 | $29,771 | $254 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 34 | $21,900 | $644 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 37 | $17,942 | $374 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 19 | $16,055 | $803 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 12 | $10,041 | $837 |
| Short return visit (20+ min) | 112 | $8,701 | $73 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 24 | $7,499 | $300 |
| Short return visit | 90 | $5,839 | $47 |
| Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | 24 | $5,296 | $221 |
| Biopsy of related skin growth, first growth | 57 | $4,737 | $75 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 24 | $3,568 | $143 |
| Destruction of precancer skin growth, 1 growth | 47 | $2,820 | $49 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 19 | $2,764 | $145 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $2,500 | $208 |
| New patient visit (30+ min) | 26 | $2,374 | $91 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 14 | $2,295 | $164 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $2,073 | $130 |
| Destruction of skin growth, 1-14 growths | 17 | $1,982 | $110 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 11 | $1,807 | $164 |
| Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less | 13 | $1,528 | $118 |
| Injection into skin growth, 1-7 growths | 27 | $1,294 | $40 |
| Biopsy of related skin growth, each additional growth | 19 | $1,170 | $49 |
| Destruction of precancer skin growth, 2-14 growths | 24 | $975 | $7 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $889 | $56 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $25 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 134 | More than 95% of doctors who do this |
| Removal of skin cancer | 587 | More than 67% of doctors who do this |
| Removal of skin lesions | 485 | More than 86% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 267 | More than 89% of doctors who do this |
Who their Medicare patients are
597 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 20% · Women 44% · Also on Medicaid 7% · Health risk score 1.19. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 71% · Chronic kidney disease 28% · Coronary heart disease 26% · Diabetes 25% · Atrial fibrillation 24% · Cancer 18% · Heart failure 16% · Depression 14% · COPD 11% · Dementia 7% · Stroke 7%.
The office billed $1,928,868, Medicare allowed $825,728 and paid $644,639; for 2,233 services of 83 kinds; $25 of it was for drugs given in the office and $644,615 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 597 | 2,233 | 77 | 1.19 | $1,928,868 | $644,639 |
| 2023 | 907 | 3,632 | 78 | 1.21 | $3,828,413 | $1,182,087 |
| 2022 | 357 | 1,309 | 78 | 1.09 | $1,382,600 | $448,187 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 30 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 648 | $374,029 | $486 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 390 | $242,202 | $388 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 110 | $75,876 | $538 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 81 | $73,883 | $890 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 67 | $55,937 | $835 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 200 | $47,016 | $227 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 153 | $39,776 | $247 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 56 | $37,467 | $669 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 62 | $35,972 | $387 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 38 | $25,904 | $682 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 29 | $25,342 | $874 |
| Short return visit | 166 | $13,652 | $50 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 38 | $11,561 | $289 |
| Short return visit (20+ min) | 160 | $11,276 | $68 |
| Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | 31 | $7,391 | $238 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 43 | $7,365 | $171 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 39 | $6,239 | $149 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | 25 | $5,194 | $200 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 35 | $4,844 | $127 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 30 | $4,657 | $155 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 28 | $4,634 | $160 |
| Biopsy of related skin growth, first growth | 39 | $3,896 | $81 |
| Injection into skin growth, 1-7 growths | 46 | $3,818 | $51 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 21 | $3,728 | $178 |
| Destruction of precancer skin growth, 1 growth | 48 | $2,425 | $46 |
| Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less | 19 | $2,365 | $118 |
| Complicated repair of wound of trunk, each additional 5.0 cm or less | 13 | $1,763 | $110 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $1,008 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 23 | $472 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | $74 | None |
2022: 22 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 226 | $138,020 | $527 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 146 | $104,071 | $407 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 43 | $26,373 | $561 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 23 | $15,957 | $665 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 54 | $15,367 | $274 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 18 | $15,262 | $848 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 55 | $13,408 | $244 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 17 | $11,908 | $700 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 21 | $11,704 | $390 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 11 | $10,419 | $947 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 35 | $8,276 | $230 |
| Short return visit (20+ min) | 81 | $6,857 | $84 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 18 | $6,529 | $363 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | 22 | $5,772 | $240 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 33 | $5,551 | $139 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 34 | $5,310 | $156 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 29 | $3,726 | $120 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 17 | $3,438 | $202 |
| Short return visit | 39 | $3,098 | $53 |
| Injection into skin growth, 1-7 growths | 14 | $949 | $53 |
| Biopsy of related skin growth, first growth | 12 | $934 | $78 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $16 | None |
Drugs they prescribed that Part D paid
$8,254
Pharmacies billed $8,254 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (25 of 910) in 2024. A higher opioid share than 9 in 10 peers; the typical dermatology clinician is at 0%.
910 generic and 0 brand-name prescriptions · $8,254 in drug cost · 353 antibiotic prescriptions to 313 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mupirocin | 455 | $3,250 | $7 |
| Doxycycline Monohydrate | 221 | $1,866 | $8 |
| Gentamicin Sulfate | 26 | $1,018 | $39 |
| Doxycycline Hyclate | 76 | $561 | $7 |
| Cephalexin | 44 | $282 | $6 |
See all 7 drugs
| Mupirocin | 455 | $3,250 | $7 |
| Doxycycline Monohydrate | 221 | $1,866 | $8 |
| Gentamicin Sulfate | 26 | $1,018 | $39 |
| Doxycycline Hyclate | 76 | $561 | $7 |
| Cephalexin | 44 | $282 | $6 |
| Ketoconazole | 12 | $181 | $15 |
| Hydrocodone-Acetaminophen | 22 | $77 | $3 |
Year by year
| 2024 | 910 | 500 | 3% (25) | 0% | $8,254 |
| 2023 | 1,232 | 643 | 5% (58) | None | $17,125 |
| 2022 | 177 | 137 | 7% (12) | 0% | $3,013 |
| 2019 | 12 | None | 0% (0) | None | $7,120 |
| 2018 | 33 | 16 | 0% (0) | None | $1,102 |
| 2017 | 21 | 11 | 0% (0) | None | $938 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Doxycycline Monohydrate | 436 | $6,002 | $14 |
| Mupirocin | 429 | $4,600 | $11 |
| Gentamicin Sulfate | 76 | $3,411 | $45 |
| Cephalexin | 121 | $1,339 | $11 |
| Doxycycline Hyclate | 52 | $631 | $12 |
| Hydrocodone-Acetaminophen | 52 | $218 | $4 |
| Triamcinolone Acetonide | 13 | $92 | $7 |
| Ciprofloxacin | 11 | $79 | $7 |
2022: 4 drugs
| Doxycycline Monohydrate | 71 | $1,165 | $16 |
| Cephalexin | 51 | $478 | $9 |
| Mupirocin | 20 | $228 | $11 |
| Hydrocodone-Acetaminophen | 12 | $46 | $4 |
Money from drug and device companies
$943 in 2025
| 2025 | 14 | 43 | None | $943 |
| 2024 | 12 | 28 | None | $627 |
| 2023 | 2 | 5 | None | $186 |
| 2022 | 1 | 2 | None | $35 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $152 | 10 payments
|
| Novartis Pharmaceuticals | Cosentyx | $127 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $119 | 5 payments
|
| Almirall | Klisyri | $72 | 3 payments
|
| Sun Pharmaceutical Industries | Winlevi | $72 | 3 payments
|
| Incyte | Opzelura | $59 | 2 payments
|
See all 43 published payments
| Abbvie | Meals · 2025-12-24 | Rinvoq | $28 |
| Genzyme | Meals · 2025-12-11 | Dupixent | $47 |
| Smith+Nephew | Meals · 2025-10-14 | Collagenase Santyl | $19 |
| Novartis Pharmaceuticals | Meals · 2025-10-08 | Rhapsido | $21 |
| Abbvie | Meals · 2025-10-01 | Skyrizi | $6 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $19 |
| Abbvie | Meals · 2025-09-18 | Skyrizi | $11 |
| Ucb | Meals · 2025-09-18 | Bimzelx | $17 |
| Incyte | Meals · 2025-09-18 | Opzelura | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-16 | Cosentyx | $19 |
| Janssen Biotech | Meals · 2025-09-10 | Tremfya | $19 |
| Abbvie | Meals · 2025-09-10 | Botox | $28 |
| Abbvie | Meals · 2025-09-10 | Botox | $4 |
| Regeneron Healthcare Solutions | Meals · 2025-08-20 | Dupixent | $16 |
| Lilly USA | Meals · 2025-08-19 | Taltz | $16 |
| Ucb | Meals · 2025-08-13 | Bimzelx | $19 |
| Almirall | Meals · 2025-08-13 | Klisyri | $28 |
| Arcutis Biotherapeutics | Meals · 2025-08-05 | Zoryve | $23 |
| Organon | Meals · 2025-07-30 | None | $31 |
| Novartis Pharmaceuticals | Meals · 2025-07-29 | Cosentyx | $20 |
| Abbvie | Meals · 2025-07-23 | Skyrizi | $6 |
| LEO Pharma | Meals · 2025-07-01 | Adbry | $24 |
| Novartis Pharmaceuticals | Meals · 2025-06-24 | Cosentyx | $23 |
| Almirall | Meals · 2025-06-19 | Klisyri | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-06-12 | Dupixent | $26 |
| Sun Pharmaceutical Industries | Meals · 2025-03-18 | Winlevi | $23 |
| Incyte | Meals · 2025-03-15 | Opzelura | $30 |
| Abbvie | Meals · 2025-03-13 | Skyrizi | $10 |
| Lilly USA | Meals · 2025-02-26 | Zepbound | $30 |
| Janssen Biotech | Meals · 2025-02-21 | Tremfya | $40 |
| Regeneron Healthcare Solutions | Meals · 2025-02-19 | Dupixent | $32 |
| LEO Pharma | Meals · 2025-02-19 | Adbry | $18 |
| Novartis Pharmaceuticals | Meals · 2025-02-11 | None | $24 |
| Novartis Pharmaceuticals | Meals · 2025-02-05 | Cosentyx | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-02-04 | Winlevi | $23 |
| Abbvie | Meals · 2025-01-31 | Skyrizi | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-01-30 | Dupixent | $18 |
| Ucb | Meals · 2025-01-23 | Bimzelx | $18 |
| Abbvie | Meals · 2025-01-22 | Skyrizi | $25 |
| Almirall | Meals · 2025-01-16 | Klisyri | $25 |
| Abbvie | Meals · 2025-01-15 | Skyrizi | $13 |
| Sun Pharmaceutical Industries | Meals · 2025-01-15 | Winlevi | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-01-09 | Dupixent | $27 |
See earlier years (2024, 2023, 2022, 2021)
2024: $627
| Abbvie | Skyrizi | $125 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $120 | 5 payments
|
| Lilly USA | Taltz | $71 | 3 payments
|
| Janssen Biotech | Tremfya | $59 | 2 payments
|
| Sun Pharmaceutical Industries | Winlevi | $55 | 2 payments
|
| MIMEDX Group | None | $53 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $33 | 2 payments
|
| Almirall | Klisyri | $30 | 1 payment
|
| Incyte | Opzelura | $30 | 1 payment
|
| STRATA Skin Sciences | Xtrac | $23 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $15 | 1 payment
|
| LEO Pharma | Adbry | $13 | 1 payment
|
2023: $186
| Arcutis Biotherapeutics | None | $103 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $83 | 4 payments
|
2022: $35
| Janssen Biotech | Remicade | $35 | 2 payments
|
2021: $125
| AbbVie | Skyrizi | $125 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1578094785
- Licence
- CA A160666California A160666: Current · expires 2027-02-28
- Trained
- University of California, Geffen School of Medicine, 2017
- Group
- Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ND0101X (207ND0101X)
- Mailing address
- 2420 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2017-03-21
- NPI last updated
- 2025-10-16
- NPI record certified
- 2025-10-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 18988 Cox Ave Ste B, Saratoga, CA, 95070